“Fixed-Duration First-Line Therapy for Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) in Canada: A Canadian Expert Clinical Framework”, Can Hematol Today, vol. 5, no. s03, pp. 2–16, Nov. 2026, doi: 10.58931/cht.2026.5s0394.